Company / R&D per Share
AMICUS THERAPEUTICS, INC. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.45
FY2025
5-year range
$0.37 / $1.04
FY2021-FY2025
Trend
+22.0%
vs FY2024
Sector context
#179 of 208
Health Care
What the data says
AMICUS THERAPEUTICS, INC.'s r&d per share of $0.45 is lower than 86% of companies in the Health Care sector (FY2025). R&D per Share returned to growth in FY2025 after 4 years of decline, reaching $0.45.
Based on SEC 10-K filings.
0.45 in FY2025 with a 5-year CAGR of -17.5%.
Declined from $0.54 to $0.45 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -22.9%
- 5-Year CAGR
- -17.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 208This company $0.45 Sector average $28.82
▼
-98.4% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 22.0% year-over-year.
- Ranks #179 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2018.
- Lowest r&d per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.45 | +22.0% |
| FY2024 | $0.37 | -31.3% |
| FY2023 | $0.54 | -45.4% |
| FY2022 | $0.99 | -4.4% |
| FY2021 | $1.04 | -12.9% |
| FY2020 | $1.19 | +0.0% |
| FY2019 | $1.19 | -18.3% |
| FY2018 | $1.46 | +39.3% |
| FY2017 | $1.05 | +24.8% |
| FY2016 | $0.84 | +4.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026